144 results on '"Shiratori, Fumiaki"'
Search Results
2. Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma
3. Preoperative low serum creatine kinase is associated with poor overall survival in the male patients with esophageal squamous cell carcinoma
4. Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers
5. Prognostic impact of CEA/CA19-9 at the time of recurrence in patients with gastric cancer
6. New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study
7. Combination of high anti‐SKI and low anti‐TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma.
8. Serum p53 antibody: useful for detecting gastric cancer but not for predicting prognosis after surgery
9. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke
10. The effectiveness of serum midkine in detecting esophageal squamous cell carcinoma
11. Urinary N1, N12-Diacetylspermine Level in the Patients with Various Cancer; A Pilot Study in Seven Types of Cancer
12. Inducing multiple antibodies to treat squamous cell esophageal carcinoma
13. A case of Barrett’s esophageal cancer with gastric mucosa-associated lymphoma
14. Is Preoperative Low Serum Calcium Level a Poor Prognostic Factor of Gastric Cancer?
15. The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
16. Is High Score of Preoperative Lactate Dehydrogenase to Albumin Ratio Predicting Poor Survivals in Esophageal Carcinoma Patients?
17. Prospective pilot study of adoptive immunotherapy with autologous αβT cells for five cases of advanced and/or recurrent esophageal squamous cell carcinoma
18. Relationship between ABO blood group and clinicopathological factors and their effect on the survival of Japanese patients with esophageal squamous cell carcinoma
19. Radical Esophagectomy Combined with Resection of the Invaded Descending Aorta for T4 Barrett's Esophageal Carcinoma: A Case Report
20. Postrecurrence Prognostic Impact of Squamous Cell Carcinoma Antigen and Serum p53 Antibody at the Time of Recurrence on the Patients with Esophageal Squamous Cell Carcinoma
21. Comparison between a new assay system, Elecsys® Anti‑p53, and conventional MESACUP™ for the detection of serum anti‑p53 antibodies: A multi‑institutional study
22. Serum WT1‑271 IgM antibody as a novel diagnostic marker for Gastric Cancer
23. Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers
24. Identification of serum anti‑striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers
25. 166 CLINICAL IMPACT OF NEW BIOMARKERS IN THE PATIENTS WITH ESOPHAGEAL CARCINOMA
26. Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
27. Preoperative low serum creatine kinase is associated with poor overall survival in the male patients with esophageal squamous cell carcinoma
28. Prevalence of serum galectin‑1 autoantibodies in seven types of cancer: A potential biomarker
29. Additional file 1 of Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke
30. Anti-KIAA0513 Antibody as a Broad-spectrum Biomarker of Mortal Atherosclerotic and Cancerous Diseases
31. A Case of Ruptured Ileocolic Artery Aneurysm with Hematoma Infection after Endovascular Treatment
32. Preoperative Low Serum Calcium Levels Predict Poor Prognosis for Patients with Esophageal Cancer
33. Possible predictive significance of serum RalA autoantibodies on relapse‑free survival in patients with colorectal cancer
34. New Assay System Elecsys Anti-p53 to Detect Serum Anti-p53 Antibodies in Esophageal Cancer Patients and Colorectal Cancer Patients: Multi-institutional Study
35. Usefulness of serum miR‑1246/miR‑106b ratio in patients with esophageal squamous cell carcinoma
36. Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases
37. Inducing multiple antibodies to treat squamous cell esophageal carcinoma
38. Prevalence of autoantibodies against Ras‑like GTPases, RalA, in patients with gastric cancer
39. Prognostic impact of p53 and/or NY‐ESO‐1 autoantibody induction in patients with gastroenterological cancers
40. High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer
41. Diagnostic impact of high serum midkine level in patients with gastric cancer
42. High serum PD‐L1 level is a poor prognostic biomarker in surgically treated esophageal cancer.
43. PS01.169: RADICAL ESOPHAGECTOMY COMBINED WITH RESECTION OF INVADED DESCENDING AORTA FOR T4 BARRETT’S ESOPHAGEAL CANCER
44. Is high serum programmed death ligand 1 level a risk factor for poor survival in patients with gastric cancer?
45. Relationship between ABO blood group and clinicopathological factors and their effect on the survival of Japanese patients with esophageal squamous cell carcinoma
46. A Case of Intussusception at Braun’s Anastomosis after Gastrojejunostomy
47. A Case of Diaphragmatic Hernia After Transhiatal Esophagectomy
48. A Case of Primary Malignant Solitary Fibrous Tumor of the Pancreas
49. A CASE OF SEVERE ULCERATIVE COLITIS ACCOMPANIED BY GASTRIC CARCINOMA TREATED BY A SIMULATANEOUS LAPAROSCOPIC SURGERY
50. Two Cases of Postoperative Ileus Due to Postesophagectomy Jejunostomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.